as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹2,385.2
Change
+59.1 (2.54%)
Open
₹2,325.9
Prev. Close
₹2,326.1
Day High
₹2,409.0
Day Low
₹2,325.9
Volume Analysis
Traded
163,069
Delivered
67,407
Delivery %
41.34%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (4)
- •High debt-to-equity ratio (1.71)
- •Low return on equity (3.58%)
- •Promoter holding is falling
- •Below-average fundamentals quality score (40/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹2,503.94 | ₹2,456.47 | ₹2,420.84 | ₹2,373.37 | ₹2,337.74 | ₹2,290.27 | ₹2,254.64 |
| Fibonacci | ₹2,456.47 | ₹2,424.73 | ₹2,405.11 | ₹2,373.37 | ₹2,341.63 | ₹2,322.01 | ₹2,290.27 |
| Camarilla | ₹2,408.05 | ₹2,400.44 | ₹2,392.82 | ₹2,373.37 | ₹2,377.58 | ₹2,369.97 | ₹2,362.35 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+102.82%
1 Week
+1.08%
1 Month
+7.94%
3 Months
+17.79%
6 Months
+101.69%
1 Year
+57.0%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹275.29
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
4.15%
Net margin 3.89% × asset turnover 0.3x × equity multiplier 3.56x
Company Overview
Sector
Chemicals
Market Cap
₹7,166 Cr
P/E (TTM)
202.0
ROE
3.58%
Book Value
₹309.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Neogen Chemicals Limited scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 40/100. The strongest factor is Momentum (92/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.71); low return on equity (3.58%).
TopFund Score — Fundamentals Quality
40/100 — WeakData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's median sales growth is 20.3% of last 10 years
- +Company's working capital requirements have reduced from 112 days to 84.6 days
- −Stock is trading at 7.71 times its book value
- −Company has low interest coverage ratio.
- −Promoter holding has decreased over last quarter: -4.69%
- −Company has a low return on equity of 4.90% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Intimation of Analyst/Investor meet to be held on September 28, 2026.
Neogen raises ~INR 600 crore in first-ever QIP, oversubscribed 6.5x, to repay debt and fund working capital.
Intimation of Analyst/Investor meeting to be held on September 22, 2026.
Neogen Chemicals allotted 26.6 lakh shares in ₹600 crore QIP at ₹2,255 on September 16, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 165 | 162 | 164 | 200 | 180 | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 |
| Expenses + | 137 | 136 | 144 | 164 | 149 | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 |
| Operating Profit | 28 | 26 | 20 | 36 | 31 | 35 | 35 | 36 | 32 | 30 | 32 | 44 | 48 |
| OPM % | 17.0% | 16.0% | 12.0% | 18.0% | 17.0% | 18.0% | 17.0% | 18.0% | 17.0% | 14.0% | 14.0% | 18.0% | 19.0% |
| Other Income + | 2 | 2 | 2 | 2 | 2 | 1 | 1 | -13 | 1 | 2 | 2 | 1 | 4 |
| Interest | 11 | 11 | 11 | 10 | 10 | 13 | 13 | 12 | 13 | 19 | 22 | 21 | 21 |
| Depreciation | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 8 |
| Profit before tax | 14 | 11 | 6 | 22 | 16 | 15 | 15 | 4 | 14 | 5 | 6 | 16 | 23 |
| Tax % | 28.0% | 28.0% | 81.0% | 25.0% | 27.0% | 29.0% | 34.0% | 35.0% | 28.0% | 35.0% | 36.0% | 28.0% | 26.0% |
| Net Profit + | 10 | 8 | 1 | 17 | 11 | 11 | 10 | 2 | 10 | 3 | 4 | 11 | 17 |
| EPS in Rs | 4 | 3 | 0 | 6 | 4 | 4 | 4 | 1 | 4 | 1 | 1 | 4 | 6 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 84 | 100 | 110 | 161 | 239 | 306 | 336 | 487 | 686 | 691 | 778 | 862 | 926 |
| Expenses + | 71 | 86 | 90 | 132 | 196 | 248 | 272 | 401 | 575 | 581 | 641 | 725 | 772 |
| Operating Profit | 13 | 14 | 20 | 29 | 43 | 58 | 64 | 87 | 112 | 110 | 136 | 137 | 154 |
| OPM % | 15.0% | 14.0% | 18.0% | 18.0% | 18.0% | 19.0% | 19.0% | 18.0% | 16.0% | 16.0% | 18.0% | 16.0% | 17.0% |
| Other Income + | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 5 | 8 | -10 | 6 | 9 |
| Interest | 5 | 5 | 8 | 10 | 12 | 12 | 14 | 19 | 29 | 42 | 48 | 75 | 83 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 5 | 7 | 12 | 16 | 23 | 28 | 28 | 30 |
| Profit before tax | 8 | 8 | 12 | 17 | 29 | 41 | 44 | 57 | 71 | 53 | 50 | 41 | 50 |
| Tax % | 37.0% | 39.0% | 33.0% | 37.0% | 28.0% | 30.0% | 29.0% | 22.0% | 30.0% | 32.0% | 31.0% | 30.0% | — |
| Net Profit + | 5 | 5 | 8 | 11 | 21 | 29 | 31 | 45 | 50 | 36 | 35 | 29 | 36 |
| EPS in Rs | 11 | 3 | 4 | 5 | 10 | 12 | 13 | 18 | 20 | 14 | 13 | 11 | 13 |
| Dividend Payout % | 18.0% | 17.0% | 0.0% | 18.0% | 14.0% | 16.0% | 17.0% | 15.0% | 15.0% | 15.0% | 8.0% | 18.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 19 | 8 | 22 | 30 | 50 | 133 | 160 | 414 | 458 | 734 | 763 | 790 |
| Borrowings + | 24 | 26 | 69 | 82 | 120 | 137 | 222 | 229 | 370 | 409 | 597 | 1,395 |
| Other Liabilities + | 21 | 26 | 41 | 48 | 56 | 61 | 87 | 131 | 202 | 292 | 361 | 691 |
| Total Liabilities | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 |
| Fixed Assets + | 13 | 17 | 56 | 67 | 83 | 111 | 127 | 285 | 347 | 496 | 404 | 475 |
| CWIP | 0 | 1 | 1 | 1 | 0 | 3 | 115 | 11 | 36 | 109 | 156 | 857 |
| Investments | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 82 | 77 | 0 | 0 | 0 |
| Other Assets + | 55 | 62 | 94 | 112 | 163 | 241 | 250 | 422 | 594 | 856 | 1,187 | 1,570 |
| Total Assets | 69 | 80 | 152 | 180 | 246 | 355 | 492 | 799 | 1,054 | 1,461 | 1,747 | 2,902 |
| Equity Capital | 4 | 20 | 20 | 20 | 20 | 23 | 23 | 25 | 25 | 26 | 26 | 26 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 9 | 9 | 0 | 12 | -4 | -35 | 84 | 1 | -30 | -29 | 196 | -231 |
| Cash from Investing Activity + | -2 | -4 | -33 | -13 | -20 | -29 | -135 | -146 | -94 | -216 | -317 | -410 |
| Cash from Financing Activity + | -6 | -4 | 33 | 0 | 24 | 63 | 51 | 188 | 100 | 237 | 113 | 642 |
| Net Cash Flow | 1 | 0 | 1 | -1 | 0 | -1 | 0 | 44 | -25 | -8 | -8 | 0 |
| CFO/OP | 89 | 83 | 21 | 55 | 4 | -38 | 146 | 13 | -17 | -18 | 153 | -154 |
| Free Cash Flow | 7 | 4 | -33 | -1 | -24 | -63 | -51 | -65 | -134 | -332 | -121 | -647 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 15.75% | 16.42% | 15.93% | 18.12% | 18.51% | 18.22% | 18.45% | 18.4% | 22.21% | 21.67% | 23.27% | 23.75% |
| Promoters | 56.89% | 56.89% | 56.89% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 51.22% | 53.0% | 48.31% |
| FII | 4.51% | 4.56% | 4.65% | 8.17% | 7.73% | 7.79% | 7.35% | 5.15% | 4.57% | 4.46% | 4.11% | 4.51% |
| DII | 22.85% | 22.14% | 22.54% | 22.48% | 22.52% | 22.75% | 22.96% | 25.22% | 21.99% | 22.65% | 19.6% | 23.43% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Neogen Chemicals Limited (this stock) | 7,166 | 202.0 | 7.72 | 3.58% |
| Balaji Amines Limited | 7,180 | 35.2 | 3.63 | 8.74% |
| Rain Industries Limited | 7,378 | 13.7 | 0.92 | 0.6% |
| Sharda Cropchem Ltd. | 6,763 | 10.8 | 2.16 | 23.2% |
| Fineotex Chemical Limited | 6,591 | 53.9 | 7.47 | 13.5% |
| Galaxy Surfactants Ltd | 7,990 | 22.0 | 2.9 | 10.9% |
| Guj State Fert & Chem Ltd | 6,180 | 8.94 | 0.5 | 5.51% |
Which Mutual Funds Hold Neogen Chemicals Limited?
Frequently Asked Questions about Neogen Chemicals Limited
Neogen Chemicals Limited (NEOGEN) closed at ₹2,385.2 on NSE on 25 September 2026, up 59.1 (2.54%) from the previous close.
Neogen Chemicals Limited trades on the NSE (National Stock Exchange of India) under the symbol NEOGEN.
Neogen Chemicals Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 202.0.
Neogen Chemicals Limited has a dividend yield of 0.04%.
Neogen Chemicals Limited's 52-week high is ₹2,500.0 and its 52-week low is ₹967.0.
Neogen Chemicals Limited has a market capitalisation of ₹7,166 crore.
Neogen Chemicals Limited has a TopFund Quality Score of 40/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Neogen Chemicals Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.